Cite
HARVARD Citation
Knebel, F. et al. (2017). Sequential liquid biopsies reveal dynamic alterations of EGFR driver mutations and indicate EGFR amplification as a new mechanism of resistance to osimertinib in NSCLC. Lung cancer. pp. 238-241. [Online].